Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome

Abstract Background Sjogren syndrome (SS) is a chronic systemic autoimmune disease and its pathogenesis often involves the participation of numerous immune cells and inflammatory factors. Despite increased researches and studies recently focusing on this area, it remains to be fully elucidated. We d...

Full description

Saved in:
Bibliographic Details
Main Authors: Jingyi Xu, Shucheng Si, Yijun Han, Lin Zeng, Jinxia Zhao
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-024-05993-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594470289276928
author Jingyi Xu
Shucheng Si
Yijun Han
Lin Zeng
Jinxia Zhao
author_facet Jingyi Xu
Shucheng Si
Yijun Han
Lin Zeng
Jinxia Zhao
author_sort Jingyi Xu
collection DOAJ
description Abstract Background Sjogren syndrome (SS) is a chronic systemic autoimmune disease and its pathogenesis often involves the participation of numerous immune cells and inflammatory factors. Despite increased researches and studies recently focusing on this area, it remains to be fully elucidated. We decide to incorporate genetic insight into investigation of the causal link between various immune cells, inflammatory factors and pathogenesis of Sjogren syndrome (SS). Methods Our study leveraged the genetic variants of multi-omics statistics extracted from genome-wide association study (GWAS), the University of Bristol and the FinnGen study. We performed a bidirectional Mendelian randomization and mediation study based on randomly allocated instrumental variables to infer causality, followed by external validation with UK Biobank data and Bayesian colocalization. Results We demonstrated that an elevated level of CD27 on IgD + CD24 + B cell, a subset of B cells expressing both IgD and CD24, was associated with a higher risk of SS (OR = 1.119, 95% CI: 1.061–1.179, P < 0.001), while CD3 on CD45RA + CD4 + Treg was a protective factor (OR = 0.917, 95%CI: 0.877–0.959, P < 0.001). Results of meta-analysis and colocalization further supported the significant results identified in the primary analysis. A total of 4 inflammatory cytokines and 7 circulating proteins exhibited potential causal relationships with SS despite no significant result achieved after FDR correction. Finally, results of mediation analysis indicated that CD40L receptor levels had significant mediating effects (β = 0.0314, 95% CI: 0.0004–0.0624, P = 0.0471) at a mediation proportion of 28% (95% CI: 0.364%-55.6%) in causal relationship between CD27 on IgD + CD24 + B cell and SS. Conclusions By providing a novel genetic insight into unveiling the roles of autoimmunity and inflammation in Sjogren syndrome, our findings may potentially lead to identifying new clinical biomarkers for disease monitoring and therapeutic targets that offer more effective alternatives for treating this condition. Therefore, our study may provide valuable evidence for future clinical intervention and targeted immunotherapy.
format Article
id doaj-art-3658d3b1beed4a9ea1daf8929ba4d6fa
institution Kabale University
issn 1479-5876
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-3658d3b1beed4a9ea1daf8929ba4d6fa2025-01-19T12:37:13ZengBMCJournal of Translational Medicine1479-58762025-01-0123111310.1186/s12967-024-05993-zGenetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndromeJingyi Xu0Shucheng Si1Yijun Han2Lin Zeng3Jinxia Zhao4Department of Rheumatology and Immunology, Peking University Third HospitalResearch Center of Clinical Epidemiology, Peking University Third HospitalDepartment of Rheumatology and Immunology, Peking University Third HospitalResearch Center of Clinical Epidemiology, Peking University Third HospitalDepartment of Rheumatology and Immunology, Peking University Third HospitalAbstract Background Sjogren syndrome (SS) is a chronic systemic autoimmune disease and its pathogenesis often involves the participation of numerous immune cells and inflammatory factors. Despite increased researches and studies recently focusing on this area, it remains to be fully elucidated. We decide to incorporate genetic insight into investigation of the causal link between various immune cells, inflammatory factors and pathogenesis of Sjogren syndrome (SS). Methods Our study leveraged the genetic variants of multi-omics statistics extracted from genome-wide association study (GWAS), the University of Bristol and the FinnGen study. We performed a bidirectional Mendelian randomization and mediation study based on randomly allocated instrumental variables to infer causality, followed by external validation with UK Biobank data and Bayesian colocalization. Results We demonstrated that an elevated level of CD27 on IgD + CD24 + B cell, a subset of B cells expressing both IgD and CD24, was associated with a higher risk of SS (OR = 1.119, 95% CI: 1.061–1.179, P < 0.001), while CD3 on CD45RA + CD4 + Treg was a protective factor (OR = 0.917, 95%CI: 0.877–0.959, P < 0.001). Results of meta-analysis and colocalization further supported the significant results identified in the primary analysis. A total of 4 inflammatory cytokines and 7 circulating proteins exhibited potential causal relationships with SS despite no significant result achieved after FDR correction. Finally, results of mediation analysis indicated that CD40L receptor levels had significant mediating effects (β = 0.0314, 95% CI: 0.0004–0.0624, P = 0.0471) at a mediation proportion of 28% (95% CI: 0.364%-55.6%) in causal relationship between CD27 on IgD + CD24 + B cell and SS. Conclusions By providing a novel genetic insight into unveiling the roles of autoimmunity and inflammation in Sjogren syndrome, our findings may potentially lead to identifying new clinical biomarkers for disease monitoring and therapeutic targets that offer more effective alternatives for treating this condition. Therefore, our study may provide valuable evidence for future clinical intervention and targeted immunotherapy.https://doi.org/10.1186/s12967-024-05993-zSjogren syndromeSjogren’s syndromeSicca syndromeImmunophenotypeMendelian randomization
spellingShingle Jingyi Xu
Shucheng Si
Yijun Han
Lin Zeng
Jinxia Zhao
Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome
Journal of Translational Medicine
Sjogren syndrome
Sjogren’s syndrome
Sicca syndrome
Immunophenotype
Mendelian randomization
title Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome
title_full Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome
title_fullStr Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome
title_full_unstemmed Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome
title_short Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome
title_sort genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of sjogren syndrome
topic Sjogren syndrome
Sjogren’s syndrome
Sicca syndrome
Immunophenotype
Mendelian randomization
url https://doi.org/10.1186/s12967-024-05993-z
work_keys_str_mv AT jingyixu geneticinsightintodissectingtheimmunophenotypesandinflammatoryprofilesinthepathogenesisofsjogrensyndrome
AT shuchengsi geneticinsightintodissectingtheimmunophenotypesandinflammatoryprofilesinthepathogenesisofsjogrensyndrome
AT yijunhan geneticinsightintodissectingtheimmunophenotypesandinflammatoryprofilesinthepathogenesisofsjogrensyndrome
AT linzeng geneticinsightintodissectingtheimmunophenotypesandinflammatoryprofilesinthepathogenesisofsjogrensyndrome
AT jinxiazhao geneticinsightintodissectingtheimmunophenotypesandinflammatoryprofilesinthepathogenesisofsjogrensyndrome